Clinical trials
Observational Neurofibromatoses trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2015 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 6 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |
| AstraZeneca | 1 |
| John Jay High School | 1 |
| Johns Hopkins University | 1 |
| King's College London | 1 |
| M.D. Anderson Cancer Center | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurofibromatoses | 19 |
| Neurofibromatosis 1 | 8 |
| Anemia, Sickle Cell | 2 |
| Neoplasms | 2 |
| Neurofibroma | 2 |
| Neurofibromatosis 2 | 2 |
| Neuroma, Acoustic | 2 |
| Tuberous Sclerosis | 2 |
| 22q11 Deletion Syndrome | 1 |
| Acrocephalosyndactylia | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.